مخطط السعر

    PRALATREXATE

    • اتصل للسعر

    المشاركة في

    الوصف

    Pralatrexate is a folate analogue metabolic inhibitor indicated for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). This indication is based on overall response rate. Clinical benefit such as improvement in progression free survival or overall survival has not been demonstrated. INDICATION Treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). This indication is based on overall response rate.

    اللغات القابلة للعرض

    English
    پارسی
    中国
    Russian
    العربية
    Spanish
    Deutsch
    اردو
    Türkçe
    Français
    Italy
    Português
    Nederlands
    हिंदी
    Հայերեն
    日本語
    انتظر لحظة...